Cargando…

Epilepsy and COVID-19: Management of Patients and Optimization of Antiepileptic Treatment in the Pandemic

There are as yet no data pointing to any increase in the incidence of the novel coronavirus infection (COVID-19) or a more severe course of illness in patients with epilepsy. However, considering the high prevalence of epilepsy in patients over 60 years of age, the high comorbidity of epilepsy and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rider, F. K., Lebedeva, A. V., Mkrtchyan, V. R., Guekht, A. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569090/
https://www.ncbi.nlm.nih.gov/pubmed/34754132
http://dx.doi.org/10.1007/s11055-021-01142-x